Next Article in Journal
Exosomes—Promising Carriers for Regulatory Therapy in Oncology
Next Article in Special Issue
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer
Previous Article in Journal
Predictive Value of Magnetic Resonance Imaging in Risk Stratification and Molecular Classification of Endometrial Cancer
 
 
Article

Article Versions Notes

Cancers 2024, 16(5), 922; https://doi.org/10.3390/cancers16050922
Action Date Notes Link
article xml file uploaded 25 February 2024 08:20 CET Original file -
article xml uploaded. 25 February 2024 08:20 CET Update https://www.mdpi.com/2072-6694/16/5/922/xml
article pdf uploaded. 25 February 2024 08:20 CET Version of Record https://www.mdpi.com/2072-6694/16/5/922/pdf
article html file updated 25 February 2024 08:22 CET Original file https://www.mdpi.com/2072-6694/16/5/922/html
Back to TopTop